Arthur Asher Kornbluth serves as Executive at CB Pharma Acquisition Corp., where they oversee executive responsibilities. Since joining the company, Arthur Asher Kornbluth has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 20, 2016 involved selling 10,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 20, 2016 | CNLM | $0 | Sale | 10,000 | $N/A | Discretionary |
Arthur Asher Kornbluth currently holds 0 shares of CB Pharma Acquisition Corp. (CNLM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arthur Asher Kornbluth has been a net neutral trader of CNLM stock. They have purchased $0 and sold $0 worth of shares.
Arthur Asher Kornbluth's most recent insider trade was on May 20, 2016, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted